Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin for Survival in Cirrhosis with Hepatic Encephalopathy
NCT02401490Phase 4Unknown
- Sponsor
- Vall d'Hebron Research Institute
- Start
- Apr 2015
- Primary completion
- Mar 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of albumin (human) in hepatic encephalopathy (HE), Cirrhosis, sponsored by Vall d'Hebron Research Institute. Status: unknown.
02
Drugs
albumin (human)
03
Conditions
hepatic encephalopathy (HE)Cirrhosis
Beyond the preview
Go deeper on NCT02401490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02401490.